Lineagen Targeting Pediatricians with New Chromosomal Microarray Testing Service
January 11, 2011
Lineagen Targeting Pediatricians with New Chromosomal Microarray Testing Service
Lineagen's new chromosomal microarray testing and genetic-counseling service, dubbed FirstStepDx, aims to appeal to pediatricians who are charged with treating children with possible autism spectrum disorder or developmental delay.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Lineagen to Update Autism Microarray Test with New Variants Discovered by CHOP, University of Utah
May 22, 2012 / BioArray News - Lineagen Incorporating Affymetrix's GeneChip Technology into Genetic Evaluation Service
March 28, 2012 / GenomeWeb Daily News - Despite Continued Genotyping Growth, Weak Expression Sales Force Affymetrix to Suspend Guidance
May 7, 2013 / BioArray News - Consumer Genetics Sales, GWAS, BlueGnome Drive Illumina Q1 Microarray Revenue Growth
April 23, 2013 / BioArray News - In Bid to Court Cancer Cyto Community, OGT Prepares CCMC-Designed Chip for Launch
February 26, 2013 / BioArray News